Atypical antipsychotics - Patients value the lower incidence of extrapyramidial side effects

被引:52
作者
Kapur, S [1 ]
Remington, G
机构
[1] CAMH, Clarke Div, Schizophrenia Program, Toronto, ON M5T 1R8, Canada
[2] CAMH, Clarke Div, PET Ctr, Toronto, ON M5T 1R8, Canada
关键词
D O I
10.1136/bmj.321.7273.1360
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1360 / 1361
页数:2
相关论文
共 8 条
  • [1] Allison DB, 1999, AM J PSYCHIAT, V156, P1686
  • [2] Motor and mental aspects of extrapyramidal syndromes
    Casey, DE
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 : 105 - 114
  • [3] Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
    Geddes, J
    Freemantle, N
    Harrison, P
    Bebbington, P
    [J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7273): : 1371 - 1376
  • [4] Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
    Henderson, DC
    Cagliero, E
    Gray, C
    Nasrallah, RA
    Hayden, DL
    Schoenfeld, DA
    Goff, DC
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) : 975 - 981
  • [5] KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
  • [6] KAPUR S, IN PRESS AM J PSYCHI
  • [7] Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
    Leucht, S
    Pitschel-Walz, G
    Abraham, D
    Kissling, W
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 35 (01) : 51 - 68
  • [8] MELTZER HY, 1995, J CLIN PSYCHOPHARM, V15, pS2, DOI 10.1097/00004714-199502001-00001